Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Malignant Solid Neoplasm 1Kidney Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1HIV Infections 1Endometrial Neoplasms 1Colonic Neoplasms 1Cigarette Smoking-Related Carcinoma 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Bevacizumab 21Paclitaxel 18Carboplatin 13pembrolizumab 11olaparib 10liposomal doxorubicin 10Gemcitabine 9Cyclophosphamide 9Specimen Handling 8Topotecan 7Magnetic Resonance Spectroscopy 7fludarabine 6Fulvestrant 6Taxes 5Immunoglobulin G 5Disulfides 5palbociclib 4niraparib 4mirvetuximab soravtansine 4Oxaliplatin 4Nivolumab 4Biopsy 4trastuzumab deruxtecan 3ipatasertib 3cediranib 3capivasertib 3atezolizumab 3aldesleukin 3Leucovorin 3Fluorouracil 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Health Promotion × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡